Gilead Sciences, Inc. (BIT:1GILD)
Italy · Delayed Price · Currency is EUR 102.70
-0.94 (-0.91%)
At close: Oct 31, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €128.99 billion as of November 3, 2025. Its market cap has increased by 29.90% in one year.
Market Cap
128.99B
Enterprise Value
142.37B
Revenue
24.79B
Ranking
n/a
PE Ratio
18.66
Stock Price
€102.70
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 128.99B, an increase of 66,226.79%. That is a compound annual growth rate of 21.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 128.99B | 16.01% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | 59.70B | -18.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.62B |
| DiaSorin | 4.14B |
| Amplifon | 3.30B |
| Philogen | 998.55M |
| EL.En. | 908.29M |
| Safilo Group | 701.72M |
| Pharmanutra | 444.63M |
| Health Italia | 54.04M |